PhRMA President and CEO Discusses Lowering Prescription Drug Prices Using Patient-Centered Medicare Legislation

PhRMA CEO and President Stephen Ubl discusses how new Medicare legislation could impact consumers at a time when patients continue to face immense financial burden. He calls on lawmakers to pass patient-centered policies that would directly lower drug costs, rather than policies that primarily benefit payers and pharma.

Ubl remarks, “As we look for ways to improve our health care system and make it more affordable, the policies we consider must pass this test: Do the changes benefit patients? The rule that begins to fix a broken prescription drug rebate system passes this test. The political games Washington is playing with the rule don’t.” Read more here.

(Source: Stephen Ubl, PhRMA, 8/2/21)